Page last updated: 2024-11-07

penicillamine and Erythroblastosis Fetalis

penicillamine has been researched along with Erythroblastosis Fetalis in 2 studies

Penicillamine: 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease.
penicillamine : An alpha-amino acid having the structure of valine substituted at the beta position with a sulfanyl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lakatos, L2
Kövér, B2
Oroszlán, G1
Vekerdy, Z2
Dvoracsek, E1

Other Studies

2 other studies available for penicillamine and Erythroblastosis Fetalis

ArticleYear
D-penicillamine therapy in ABO hemolytic disease of the newborn infant.
    European journal of pediatrics, 1976, Sep-01, Volume: 123, Issue:2

    Topics: ABO Blood-Group System; Age Factors; Bilirubin; Erythroblastosis, Fetal; Exchange Transfusion, Whole

1976
[Penicillamine D therapy of hemolytic disease of newborn and neonatal hyperbilirubinemia].
    Orvosi hetilap, 1975, Aug-10, Volume: 116, Issue:32

    Topics: Erythroblastosis, Fetal; Female; Humans; Hyperbilirubinemia; Infant, Newborn; Jaundice, Neonatal; Pe

1975